Formula Growth’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Formula Growth’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32,942	Closed	-$2.36M	–	143
2022 Q2	$2.36M	Sell	32,942 -22,000	-40%	-$1.61M	0.65%	61
2022 Q1	$4.45M	Sell	54,942 -28,545	-34%	-$2.41M	0.84%	47
2021 Q4	$8.57M	Sell	83,487 -4,646	-5%	-$446K	1.52%	18
2021 Q3	$7.71M	Hold	88,133	–	–	1.1%	24
2021 Q2	$7.89M	Buy	88,133 +50,000	+131%	+$4.22M	1.09%	26
2021 Q1	$2.89M	Sell	38,133 -80,000	-68%	-$6.03M	0.42%	73
2020 Q4	$8.05M	Buy	+118,133	New	+$7.36M	1.34%	21

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Formula Growth's SYNH Position: Q3 2022 in Review

Formula Growth sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 32,942 shares — an estimated $2.36M sold.

Formula Growth first reported a position in SYNH in Q4 2020 and held it in 7 quarters. The position peaked at $8.57M in Q4 2021. 336 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Formula Growth reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Formula Growth sold 32,942 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $2.36M.
Formula Growth first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 7 quarters.
Formula Growth's Syneos Health, Inc. Class A Common Stock position peaked at $8.57M in Q4 2021.
336 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Formula Growth's 13F filing for Q3 2022, filed 10 Nov 2022.